Genomic Vision SA
PAR:GV

Watchlist Manager
Genomic Vision SA Logo
Genomic Vision SA
PAR:GV
Watchlist
Price: 0.0018 EUR
Market Cap: 694.6k EUR

Genomic Vision SA
Cash from Operating Activities

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Genomic Vision SA
Cash from Operating Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Genomic Vision SA
PAR:GV
Cash from Operating Activities
-€5.4m
CAGR 3-Years
-18%
CAGR 5-Years
0%
CAGR 10-Years
N/A
Valneva SE
PAR:VLA
Cash from Operating Activities
-€18m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Nanobiotix SA
PAR:NANO
Cash from Operating Activities
-€31.2m
CAGR 3-Years
1%
CAGR 5-Years
1%
CAGR 10-Years
-10%
Inventiva SA
PAR:IVA
Cash from Operating Activities
-€162m
CAGR 3-Years
-37%
CAGR 5-Years
-53%
CAGR 10-Years
N/A
DBV Technologies SA
PAR:DBV
Cash from Operating Activities
-$87m
CAGR 3-Years
-116%
CAGR 5-Years
8%
CAGR 10-Years
-14%
Abivax SA
PAR:ABVX
Cash from Operating Activities
-€135m
CAGR 3-Years
-42%
CAGR 5-Years
-41%
CAGR 10-Years
N/A
No Stocks Found

Genomic Vision SA
Glance View

Market Cap
693.2k EUR
Industry
Biotechnology

Génomic Vision SA is a molecular diagnostics and technology company, which develops and commercializes research tools and tests for the early detection of cancers and genetic diseases. The company is headquartered in Bagneux, Ile-De-France. The company went IPO on 2014-04-02. The company develops and commercializes single-DNA molecule diagnostic tests and research tools for life sciences, cancer and genetic diseases. The firm uses the molecular combining technique for the direct visualization of single DNA molecules to detect quantitative and qualitative changes in the genome landscape and establish their contribution to pathology. The company develops its products and services in three main markets: the medical diagnostic market focusing on DNA diagnostics (cancer genomics, genetic diseases); the pharmaceutical research and development market in the fields of genomics, to develop tests that can help physicians identify how patients are likely to respond to targeted therapies (personalized medicine, pharmacogenomics, cancer cell proliferation); and the academic laboratories research market, providing molecular combining tools for academic research in the field of cancer genetics, cytogenetics and DNA replication.

GV Intrinsic Value
Not Available

See Also

What is Genomic Vision SA's Cash from Operating Activities?
Cash from Operating Activities
-5.4m EUR

Based on the financial report for Jun 30, 2023, Genomic Vision SA's Cash from Operating Activities amounts to -5.4m EUR.

What is Genomic Vision SA's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
0%

Over the last year, the Cash from Operating Activities growth was -29%. The average annual Cash from Operating Activities growth rates for Genomic Vision SA have been -18% over the past three years .

Back to Top